|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current assets: | |||||
| Cash and cash equivalents | |||||
| Short-term marketable securities | |||||
| Accounts receivable, net of allowance for credit losses of $6,706 and $6,092 as of June 30, 2026 and December 31, 2025, respectively | |||||
| Deferred commissions | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Total current assets | |||||
| Long-term marketable securities | |||||
| Goodwill | |||||
| Intangible assets, net | |||||
| Property, equipment and software, net | |||||
| Operating lease right-of-use assets | |||||
| Other assets | |||||
| Total assets | |||||
| Liabilities, redeemable convertible preferred stock and stockholders’ equity | |||||
| Current liabilities: | |||||
| Accounts payable and accrued liabilities | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Total current liabilities | |||||
| Operating lease liabilities, noncurrent | |||||
| Total liabilities | |||||
| Redeemable convertible preferred stock: | |||||
| Redeemable convertible preferred stock, $0.00001 par value; 4,330,341 shares of Series E authorized as of June 30, 2026 and December 31, 2025; 0 shares and 2,581,837 shares of Series E preferred stock issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; aggregate liquidation preference of $0 and $200,000 as of June 30, 2026 and December 31, 2025, respectively | |||||
| Stockholders’ equity: | |||||
| Common stock, value | |||||
| Class A Common Stock | |||||
| Class B Common Stock | |||||
| Total common stock, value | |||||
| Additional paid-in capital | |||||
| Accumulated other comprehensive loss | |||||
| Accumulated deficit | |||||
| Total stockholders’ equity | |||||
| Total liabilities, redeemable convertible preferred stock and stockholders’ equity |
Loading...
